nodes	percent_of_prediction	percent_of_DWPC	metapath
Riluzole—SLC7A11—Sulfasalazine—ankylosing spondylitis	0.626	0.763	CbGbCtD
Riluzole—ABCG2—Sulfasalazine—ankylosing spondylitis	0.0821	0.1	CbGbCtD
Riluzole—ABCG2—Dexamethasone—ankylosing spondylitis	0.041	0.05	CbGbCtD
Riluzole—CYP1A1—Dexamethasone—ankylosing spondylitis	0.0378	0.0461	CbGbCtD
Riluzole—ABCG2—Methotrexate—ankylosing spondylitis	0.0329	0.0402	CbGbCtD
Riluzole—SLC7A11—Betamethasone—Methylprednisolone—ankylosing spondylitis	0.000576	0.105	CbGdCrCtD
Riluzole—SLC7A11—Dexamethasone—Methylprednisolone—ankylosing spondylitis	0.000576	0.105	CbGdCrCtD
Riluzole—SLC7A11—Betamethasone—Dexamethasone—ankylosing spondylitis	0.000567	0.104	CbGdCrCtD
Riluzole—SLC7A11—Dexamethasone—Betamethasone—ankylosing spondylitis	0.000567	0.104	CbGdCrCtD
Riluzole—SLC7A11—Betamethasone—Triamcinolone—ankylosing spondylitis	0.000554	0.101	CbGdCrCtD
Riluzole—SLC7A11—Dexamethasone—Triamcinolone—ankylosing spondylitis	0.000554	0.101	CbGdCrCtD
Riluzole—SLC7A11—Dexamethasone—Prednisone—ankylosing spondylitis	0.000525	0.0961	CbGdCrCtD
Riluzole—SLC7A11—Betamethasone—Prednisone—ankylosing spondylitis	0.000525	0.0961	CbGdCrCtD
Riluzole—SLC7A11—Dexamethasone—Prednisolone—ankylosing spondylitis	0.000513	0.0938	CbGdCrCtD
Riluzole—SLC7A11—Betamethasone—Prednisolone—ankylosing spondylitis	0.000513	0.0938	CbGdCrCtD
Riluzole—Shock—Triamcinolone—ankylosing spondylitis	0.00014	0.000805	CcSEcCtD
Riluzole—Insomnia—Prednisolone—ankylosing spondylitis	0.00014	0.000805	CcSEcCtD
Riluzole—Alopecia—Prednisone—ankylosing spondylitis	0.00014	0.000804	CcSEcCtD
Riluzole—Shock—Methylprednisolone—ankylosing spondylitis	0.00014	0.000803	CcSEcCtD
Riluzole—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.00014	0.000801	CcSEcCtD
Riluzole—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00014	0.000801	CcSEcCtD
Riluzole—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000139	0.0008	CcSEcCtD
Riluzole—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000139	0.0008	CcSEcCtD
Riluzole—Epistaxis—Methotrexate—ankylosing spondylitis	0.000139	0.000799	CcSEcCtD
Riluzole—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000139	0.000799	CcSEcCtD
Riluzole—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000139	0.000799	CcSEcCtD
Riluzole—Mental disorder—Prednisone—ankylosing spondylitis	0.000139	0.000797	CcSEcCtD
Riluzole—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000139	0.000797	CcSEcCtD
Riluzole—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000138	0.000793	CcSEcCtD
Riluzole—Malnutrition—Prednisone—ankylosing spondylitis	0.000138	0.000792	CcSEcCtD
Riluzole—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000138	0.000791	CcSEcCtD
Riluzole—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.000138	0.000791	CcSEcCtD
Riluzole—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000138	0.000789	CcSEcCtD
Riluzole—Convulsion—Betamethasone—ankylosing spondylitis	0.000137	0.000788	CcSEcCtD
Riluzole—Convulsion—Dexamethasone—ankylosing spondylitis	0.000137	0.000788	CcSEcCtD
Riluzole—Hypertension—Betamethasone—ankylosing spondylitis	0.000137	0.000785	CcSEcCtD
Riluzole—Hypertension—Dexamethasone—ankylosing spondylitis	0.000137	0.000785	CcSEcCtD
Riluzole—Myalgia—Dexamethasone—ankylosing spondylitis	0.000135	0.000775	CcSEcCtD
Riluzole—Myalgia—Betamethasone—ankylosing spondylitis	0.000135	0.000775	CcSEcCtD
Riluzole—Anxiety—Betamethasone—ankylosing spondylitis	0.000135	0.000772	CcSEcCtD
Riluzole—Anxiety—Dexamethasone—ankylosing spondylitis	0.000135	0.000772	CcSEcCtD
Riluzole—Discomfort—Betamethasone—ankylosing spondylitis	0.000133	0.000765	CcSEcCtD
Riluzole—Discomfort—Dexamethasone—ankylosing spondylitis	0.000133	0.000765	CcSEcCtD
Riluzole—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000133	0.000764	CcSEcCtD
Riluzole—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000133	0.000763	CcSEcCtD
Riluzole—Pain—Prednisolone—ankylosing spondylitis	0.000133	0.000761	CcSEcCtD
Riluzole—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000133	0.000761	CcSEcCtD
Riluzole—Hepatitis—Methotrexate—ankylosing spondylitis	0.000133	0.000761	CcSEcCtD
Riluzole—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000132	0.000755	CcSEcCtD
Riluzole—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000131	0.000751	CcSEcCtD
Riluzole—Urethral disorder—Methotrexate—ankylosing spondylitis	0.00013	0.000746	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00013	0.000746	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00013	0.000744	CcSEcCtD
Riluzole—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000129	0.000742	CcSEcCtD
Riluzole—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000129	0.000742	CcSEcCtD
Riluzole—Oedema—Dexamethasone—ankylosing spondylitis	0.000129	0.000742	CcSEcCtD
Riluzole—Oedema—Betamethasone—ankylosing spondylitis	0.000129	0.000742	CcSEcCtD
Riluzole—Insomnia—Triamcinolone—ankylosing spondylitis	0.000129	0.00074	CcSEcCtD
Riluzole—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000129	0.000738	CcSEcCtD
Riluzole—Infection—Dexamethasone—ankylosing spondylitis	0.000129	0.000738	CcSEcCtD
Riluzole—Infection—Betamethasone—ankylosing spondylitis	0.000129	0.000738	CcSEcCtD
Riluzole—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000128	0.000735	CcSEcCtD
Riluzole—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000128	0.000735	CcSEcCtD
Riluzole—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000128	0.000733	CcSEcCtD
Riluzole—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000128	0.000733	CcSEcCtD
Riluzole—Anaemia—Prednisone—ankylosing spondylitis	0.000128	0.000732	CcSEcCtD
Riluzole—Shock—Dexamethasone—ankylosing spondylitis	0.000127	0.00073	CcSEcCtD
Riluzole—Shock—Betamethasone—ankylosing spondylitis	0.000127	0.00073	CcSEcCtD
Riluzole—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000127	0.00073	CcSEcCtD
Riluzole—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000127	0.000728	CcSEcCtD
Riluzole—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000127	0.000728	CcSEcCtD
Riluzole—Agitation—Prednisone—ankylosing spondylitis	0.000127	0.000728	CcSEcCtD
Riluzole—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000127	0.000727	CcSEcCtD
Riluzole—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000127	0.000727	CcSEcCtD
Riluzole—Tachycardia—Betamethasone—ankylosing spondylitis	0.000126	0.000725	CcSEcCtD
Riluzole—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000126	0.000725	CcSEcCtD
Riluzole—Angioedema—Prednisone—ankylosing spondylitis	0.000126	0.000724	CcSEcCtD
Riluzole—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000126	0.00072	CcSEcCtD
Riluzole—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000125	0.000719	CcSEcCtD
Riluzole—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000125	0.000719	CcSEcCtD
Riluzole—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000125	0.000718	CcSEcCtD
Riluzole—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000125	0.000718	CcSEcCtD
Riluzole—Malaise—Prednisone—ankylosing spondylitis	0.000125	0.000714	CcSEcCtD
Riluzole—Vertigo—Prednisone—ankylosing spondylitis	0.000124	0.000712	CcSEcCtD
Riluzole—Eye disorder—Methotrexate—ankylosing spondylitis	0.000124	0.000711	CcSEcCtD
Riluzole—Syncope—Prednisone—ankylosing spondylitis	0.000124	0.00071	CcSEcCtD
Riluzole—Anorexia—Betamethasone—ankylosing spondylitis	0.000123	0.000708	CcSEcCtD
Riluzole—Anorexia—Dexamethasone—ankylosing spondylitis	0.000123	0.000708	CcSEcCtD
Riluzole—Urticaria—Prednisolone—ankylosing spondylitis	0.000123	0.000707	CcSEcCtD
Riluzole—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000123	0.000706	CcSEcCtD
Riluzole—Fatigue—Triamcinolone—ankylosing spondylitis	0.000123	0.000705	CcSEcCtD
Riluzole—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000123	0.000704	CcSEcCtD
Riluzole—Pain—Triamcinolone—ankylosing spondylitis	0.000122	0.0007	CcSEcCtD
Riluzole—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000121	0.000696	CcSEcCtD
Riluzole—Hypotension—Betamethasone—ankylosing spondylitis	0.000121	0.000694	CcSEcCtD
Riluzole—Hypotension—Dexamethasone—ankylosing spondylitis	0.000121	0.000694	CcSEcCtD
Riluzole—Angiopathy—Methotrexate—ankylosing spondylitis	0.00012	0.00069	CcSEcCtD
Riluzole—Immune system disorder—Methotrexate—ankylosing spondylitis	0.00012	0.000687	CcSEcCtD
Riluzole—Convulsion—Prednisone—ankylosing spondylitis	0.00012	0.000686	CcSEcCtD
Riluzole—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.00012	0.000685	CcSEcCtD
Riluzole—Hypertension—Prednisone—ankylosing spondylitis	0.000119	0.000684	CcSEcCtD
Riluzole—Chills—Methotrexate—ankylosing spondylitis	0.000119	0.000682	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000118	0.000676	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000118	0.000676	CcSEcCtD
Riluzole—Myalgia—Prednisone—ankylosing spondylitis	0.000118	0.000674	CcSEcCtD
Riluzole—Arthralgia—Prednisone—ankylosing spondylitis	0.000118	0.000674	CcSEcCtD
Riluzole—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000118	0.000674	CcSEcCtD
Riluzole—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000117	0.000673	CcSEcCtD
Riluzole—Anxiety—Prednisone—ankylosing spondylitis	0.000117	0.000672	CcSEcCtD
Riluzole—Alopecia—Methotrexate—ankylosing spondylitis	0.000117	0.000672	CcSEcCtD
Riluzole—Insomnia—Dexamethasone—ankylosing spondylitis	0.000117	0.000672	CcSEcCtD
Riluzole—Insomnia—Betamethasone—ankylosing spondylitis	0.000117	0.000672	CcSEcCtD
Riluzole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000117	0.00067	CcSEcCtD
Riluzole—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000116	0.000668	CcSEcCtD
Riluzole—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000116	0.000667	CcSEcCtD
Riluzole—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000116	0.000667	CcSEcCtD
Riluzole—Discomfort—Prednisone—ankylosing spondylitis	0.000116	0.000666	CcSEcCtD
Riluzole—Mental disorder—Methotrexate—ankylosing spondylitis	0.000116	0.000666	CcSEcCtD
Riluzole—Malnutrition—Methotrexate—ankylosing spondylitis	0.000115	0.000662	CcSEcCtD
Riluzole—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000114	0.000656	CcSEcCtD
Riluzole—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000114	0.000654	CcSEcCtD
Riluzole—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000114	0.000654	CcSEcCtD
Riluzole—Urticaria—Triamcinolone—ankylosing spondylitis	0.000113	0.00065	CcSEcCtD
Riluzole—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000113	0.000649	CcSEcCtD
Riluzole—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000113	0.000648	CcSEcCtD
Riluzole—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000113	0.000647	CcSEcCtD
Riluzole—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000113	0.000647	CcSEcCtD
Riluzole—Oedema—Prednisone—ankylosing spondylitis	0.000113	0.000647	CcSEcCtD
Riluzole—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000113	0.000645	CcSEcCtD
Riluzole—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000113	0.000645	CcSEcCtD
Riluzole—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000113	0.000645	CcSEcCtD
Riluzole—Infection—Prednisone—ankylosing spondylitis	0.000112	0.000642	CcSEcCtD
Riluzole—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000112	0.000641	CcSEcCtD
Riluzole—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000112	0.000641	CcSEcCtD
Riluzole—Back pain—Methotrexate—ankylosing spondylitis	0.000112	0.00064	CcSEcCtD
Riluzole—Fatigue—Betamethasone—ankylosing spondylitis	0.000112	0.00064	CcSEcCtD
Riluzole—Fatigue—Dexamethasone—ankylosing spondylitis	0.000112	0.00064	CcSEcCtD
Riluzole—Shock—Prednisone—ankylosing spondylitis	0.000111	0.000636	CcSEcCtD
Riluzole—Pain—Dexamethasone—ankylosing spondylitis	0.000111	0.000635	CcSEcCtD
Riluzole—Pain—Betamethasone—ankylosing spondylitis	0.000111	0.000635	CcSEcCtD
Riluzole—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000111	0.000634	CcSEcCtD
Riluzole—Tachycardia—Prednisone—ankylosing spondylitis	0.00011	0.000631	CcSEcCtD
Riluzole—Skin disorder—Prednisone—ankylosing spondylitis	0.00011	0.000628	CcSEcCtD
Riluzole—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000109	0.000625	CcSEcCtD
Riluzole—Anorexia—Prednisone—ankylosing spondylitis	0.000107	0.000616	CcSEcCtD
Riluzole—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000107	0.000614	CcSEcCtD
Riluzole—Anaemia—Methotrexate—ankylosing spondylitis	0.000107	0.000612	CcSEcCtD
Riluzole—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000107	0.000612	CcSEcCtD
Riluzole—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000107	0.000612	CcSEcCtD
Riluzole—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000106	0.000607	CcSEcCtD
Riluzole—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000106	0.000607	CcSEcCtD
Riluzole—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000105	0.000603	CcSEcCtD
Riluzole—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000105	0.000602	CcSEcCtD
Riluzole—Malaise—Methotrexate—ankylosing spondylitis	0.000104	0.000597	CcSEcCtD
Riluzole—Vertigo—Methotrexate—ankylosing spondylitis	0.000104	0.000595	CcSEcCtD
Riluzole—Leukopenia—Methotrexate—ankylosing spondylitis	0.000103	0.000593	CcSEcCtD
Riluzole—Urticaria—Betamethasone—ankylosing spondylitis	0.000103	0.00059	CcSEcCtD
Riluzole—Urticaria—Dexamethasone—ankylosing spondylitis	0.000103	0.00059	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000103	0.000589	CcSEcCtD
Riluzole—Dizziness—Prednisolone—ankylosing spondylitis	0.000103	0.000588	CcSEcCtD
Riluzole—Asthenia—Triamcinolone—ankylosing spondylitis	0.000102	0.000587	CcSEcCtD
Riluzole—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000102	0.000587	CcSEcCtD
Riluzole—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000102	0.000587	CcSEcCtD
Riluzole—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000102	0.000587	CcSEcCtD
Riluzole—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000102	0.000587	CcSEcCtD
Riluzole—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000102	0.000586	CcSEcCtD
Riluzole—Insomnia—Prednisone—ankylosing spondylitis	0.000102	0.000585	CcSEcCtD
Riluzole—Paraesthesia—Prednisone—ankylosing spondylitis	0.000101	0.000581	CcSEcCtD
Riluzole—Pruritus—Triamcinolone—ankylosing spondylitis	0.000101	0.000579	CcSEcCtD
Riluzole—Cough—Methotrexate—ankylosing spondylitis	0.000101	0.000578	CcSEcCtD
Riluzole—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000101	0.000578	CcSEcCtD
Riluzole—Convulsion—Methotrexate—ankylosing spondylitis	0.0001	0.000574	CcSEcCtD
Riluzole—Dyspepsia—Prednisone—ankylosing spondylitis	9.92e-05	0.000569	CcSEcCtD
Riluzole—Chest pain—Methotrexate—ankylosing spondylitis	9.83e-05	0.000564	CcSEcCtD
Riluzole—Myalgia—Methotrexate—ankylosing spondylitis	9.83e-05	0.000564	CcSEcCtD
Riluzole—Arthralgia—Methotrexate—ankylosing spondylitis	9.83e-05	0.000564	CcSEcCtD
Riluzole—Decreased appetite—Prednisone—ankylosing spondylitis	9.8e-05	0.000562	CcSEcCtD
Riluzole—Rash—Prednisolone—ankylosing spondylitis	9.78e-05	0.000561	CcSEcCtD
Riluzole—Dermatitis—Prednisolone—ankylosing spondylitis	9.77e-05	0.000561	CcSEcCtD
Riluzole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	9.76e-05	0.00056	CcSEcCtD
Riluzole—Diarrhoea—Methylprednisolone—ankylosing spondylitis	9.74e-05	0.000559	CcSEcCtD
Riluzole—Fatigue—Prednisone—ankylosing spondylitis	9.72e-05	0.000557	CcSEcCtD
Riluzole—Headache—Prednisolone—ankylosing spondylitis	9.72e-05	0.000557	CcSEcCtD
Riluzole—Discomfort—Methotrexate—ankylosing spondylitis	9.71e-05	0.000557	CcSEcCtD
Riluzole—Constipation—Prednisone—ankylosing spondylitis	9.64e-05	0.000553	CcSEcCtD
Riluzole—Confusional state—Methotrexate—ankylosing spondylitis	9.5e-05	0.000545	CcSEcCtD
Riluzole—Dizziness—Triamcinolone—ankylosing spondylitis	9.44e-05	0.000541	CcSEcCtD
Riluzole—Anaphylactic shock—Methotrexate—ankylosing spondylitis	9.42e-05	0.00054	CcSEcCtD
Riluzole—Dizziness—Methylprednisolone—ankylosing spondylitis	9.41e-05	0.00054	CcSEcCtD
Riluzole—Infection—Methotrexate—ankylosing spondylitis	9.36e-05	0.000537	CcSEcCtD
Riluzole—Feeling abnormal—Prednisone—ankylosing spondylitis	9.29e-05	0.000533	CcSEcCtD
Riluzole—Asthenia—Dexamethasone—ankylosing spondylitis	9.29e-05	0.000533	CcSEcCtD
Riluzole—Asthenia—Betamethasone—ankylosing spondylitis	9.29e-05	0.000533	CcSEcCtD
Riluzole—Nervous system disorder—Methotrexate—ankylosing spondylitis	9.24e-05	0.00053	CcSEcCtD
Riluzole—Thrombocytopenia—Methotrexate—ankylosing spondylitis	9.23e-05	0.000529	CcSEcCtD
Riluzole—Gastrointestinal pain—Prednisone—ankylosing spondylitis	9.22e-05	0.000529	CcSEcCtD
Riluzole—Nausea—Prednisolone—ankylosing spondylitis	9.22e-05	0.000529	CcSEcCtD
Riluzole—Pruritus—Dexamethasone—ankylosing spondylitis	9.16e-05	0.000525	CcSEcCtD
Riluzole—Pruritus—Betamethasone—ankylosing spondylitis	9.16e-05	0.000525	CcSEcCtD
Riluzole—Skin disorder—Methotrexate—ankylosing spondylitis	9.15e-05	0.000525	CcSEcCtD
Riluzole—Hyperhidrosis—Methotrexate—ankylosing spondylitis	9.11e-05	0.000522	CcSEcCtD
Riluzole—Vomiting—Triamcinolone—ankylosing spondylitis	9.07e-05	0.00052	CcSEcCtD
Riluzole—Vomiting—Methylprednisolone—ankylosing spondylitis	9.05e-05	0.000519	CcSEcCtD
Riluzole—Rash—Triamcinolone—ankylosing spondylitis	9e-05	0.000516	CcSEcCtD
Riluzole—Dermatitis—Triamcinolone—ankylosing spondylitis	8.99e-05	0.000515	CcSEcCtD
Riluzole—Anorexia—Methotrexate—ankylosing spondylitis	8.98e-05	0.000515	CcSEcCtD
Riluzole—Rash—Methylprednisolone—ankylosing spondylitis	8.98e-05	0.000515	CcSEcCtD
Riluzole—Dermatitis—Methylprednisolone—ankylosing spondylitis	8.97e-05	0.000514	CcSEcCtD
Riluzole—Urticaria—Prednisone—ankylosing spondylitis	8.96e-05	0.000514	CcSEcCtD
Riluzole—Headache—Triamcinolone—ankylosing spondylitis	8.94e-05	0.000513	CcSEcCtD
Riluzole—Headache—Methylprednisolone—ankylosing spondylitis	8.92e-05	0.000511	CcSEcCtD
Riluzole—Body temperature increased—Prednisone—ankylosing spondylitis	8.91e-05	0.000511	CcSEcCtD
Riluzole—Abdominal pain—Prednisone—ankylosing spondylitis	8.91e-05	0.000511	CcSEcCtD
Riluzole—Diarrhoea—Dexamethasone—ankylosing spondylitis	8.86e-05	0.000508	CcSEcCtD
Riluzole—Diarrhoea—Betamethasone—ankylosing spondylitis	8.86e-05	0.000508	CcSEcCtD
Riluzole—Hypotension—Methotrexate—ankylosing spondylitis	8.8e-05	0.000505	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	8.58e-05	0.000492	CcSEcCtD
Riluzole—Dizziness—Dexamethasone—ankylosing spondylitis	8.56e-05	0.000491	CcSEcCtD
Riluzole—Dizziness—Betamethasone—ankylosing spondylitis	8.56e-05	0.000491	CcSEcCtD
Riluzole—Insomnia—Methotrexate—ankylosing spondylitis	8.52e-05	0.000489	CcSEcCtD
Riluzole—Nausea—Triamcinolone—ankylosing spondylitis	8.48e-05	0.000486	CcSEcCtD
Riluzole—Paraesthesia—Methotrexate—ankylosing spondylitis	8.46e-05	0.000485	CcSEcCtD
Riluzole—Nausea—Methylprednisolone—ankylosing spondylitis	8.46e-05	0.000485	CcSEcCtD
Riluzole—Dyspnoea—Methotrexate—ankylosing spondylitis	8.4e-05	0.000482	CcSEcCtD
Riluzole—Somnolence—Methotrexate—ankylosing spondylitis	8.38e-05	0.00048	CcSEcCtD
Riluzole—Hypersensitivity—Prednisone—ankylosing spondylitis	8.31e-05	0.000476	CcSEcCtD
Riluzole—Dyspepsia—Methotrexate—ankylosing spondylitis	8.29e-05	0.000476	CcSEcCtD
Riluzole—Vomiting—Betamethasone—ankylosing spondylitis	8.23e-05	0.000472	CcSEcCtD
Riluzole—Vomiting—Dexamethasone—ankylosing spondylitis	8.23e-05	0.000472	CcSEcCtD
Riluzole—Decreased appetite—Methotrexate—ankylosing spondylitis	8.19e-05	0.00047	CcSEcCtD
Riluzole—Rash—Betamethasone—ankylosing spondylitis	8.16e-05	0.000468	CcSEcCtD
Riluzole—Rash—Dexamethasone—ankylosing spondylitis	8.16e-05	0.000468	CcSEcCtD
Riluzole—Dermatitis—Betamethasone—ankylosing spondylitis	8.16e-05	0.000468	CcSEcCtD
Riluzole—Dermatitis—Dexamethasone—ankylosing spondylitis	8.16e-05	0.000468	CcSEcCtD
Riluzole—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	8.13e-05	0.000467	CcSEcCtD
Riluzole—Fatigue—Methotrexate—ankylosing spondylitis	8.12e-05	0.000466	CcSEcCtD
Riluzole—Headache—Betamethasone—ankylosing spondylitis	8.11e-05	0.000465	CcSEcCtD
Riluzole—Headache—Dexamethasone—ankylosing spondylitis	8.11e-05	0.000465	CcSEcCtD
Riluzole—Asthenia—Prednisone—ankylosing spondylitis	8.09e-05	0.000464	CcSEcCtD
Riluzole—Pain—Methotrexate—ankylosing spondylitis	8.06e-05	0.000462	CcSEcCtD
Riluzole—Pruritus—Prednisone—ankylosing spondylitis	7.98e-05	0.000457	CcSEcCtD
Riluzole—Feeling abnormal—Methotrexate—ankylosing spondylitis	7.76e-05	0.000445	CcSEcCtD
Riluzole—Diarrhoea—Prednisone—ankylosing spondylitis	7.71e-05	0.000442	CcSEcCtD
Riluzole—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	7.71e-05	0.000442	CcSEcCtD
Riluzole—Nausea—Betamethasone—ankylosing spondylitis	7.69e-05	0.000441	CcSEcCtD
Riluzole—Nausea—Dexamethasone—ankylosing spondylitis	7.69e-05	0.000441	CcSEcCtD
Riluzole—Urticaria—Methotrexate—ankylosing spondylitis	7.49e-05	0.000429	CcSEcCtD
Riluzole—Dizziness—Prednisone—ankylosing spondylitis	7.46e-05	0.000428	CcSEcCtD
Riluzole—Abdominal pain—Methotrexate—ankylosing spondylitis	7.45e-05	0.000427	CcSEcCtD
Riluzole—Body temperature increased—Methotrexate—ankylosing spondylitis	7.45e-05	0.000427	CcSEcCtD
Riluzole—Vomiting—Prednisone—ankylosing spondylitis	7.17e-05	0.000411	CcSEcCtD
Riluzole—Rash—Prednisone—ankylosing spondylitis	7.11e-05	0.000408	CcSEcCtD
Riluzole—Dermatitis—Prednisone—ankylosing spondylitis	7.1e-05	0.000407	CcSEcCtD
Riluzole—Headache—Prednisone—ankylosing spondylitis	7.06e-05	0.000405	CcSEcCtD
Riluzole—Hypersensitivity—Methotrexate—ankylosing spondylitis	6.94e-05	0.000398	CcSEcCtD
Riluzole—Asthenia—Methotrexate—ankylosing spondylitis	6.76e-05	0.000388	CcSEcCtD
Riluzole—Nausea—Prednisone—ankylosing spondylitis	6.7e-05	0.000384	CcSEcCtD
Riluzole—Pruritus—Methotrexate—ankylosing spondylitis	6.67e-05	0.000382	CcSEcCtD
Riluzole—Diarrhoea—Methotrexate—ankylosing spondylitis	6.45e-05	0.00037	CcSEcCtD
Riluzole—Dizziness—Methotrexate—ankylosing spondylitis	6.23e-05	0.000357	CcSEcCtD
Riluzole—Vomiting—Methotrexate—ankylosing spondylitis	5.99e-05	0.000344	CcSEcCtD
Riluzole—Rash—Methotrexate—ankylosing spondylitis	5.94e-05	0.000341	CcSEcCtD
Riluzole—Dermatitis—Methotrexate—ankylosing spondylitis	5.94e-05	0.00034	CcSEcCtD
Riluzole—Headache—Methotrexate—ankylosing spondylitis	5.9e-05	0.000339	CcSEcCtD
Riluzole—Nausea—Methotrexate—ankylosing spondylitis	5.6e-05	0.000321	CcSEcCtD
